Search results
Results from the WOW.Com Content Network
Foreigner registration is a mandatory requirement by the Government of India under which all foreign nationals (excluding overseas citizens of India) visiting India on a long term visa (more than 180 days) are required to register themselves with a Registration Officer within 14 days of arriving in India. [2]
From 1 April 2017 e-visas are granted under three categories of tourist, business and medical. The window for application under e-visa scheme was increased from 30 days to 120 days, and duration of stay on e-visa was increased from 30 days to 60 days, with double entry on e-tourist and e-business visa, and triple entry on e-medical visa. [83]
The Bureau of Immigration (BoI) is an Indian government agency, working under the Ministry of Home Affairs responsible for administering immigration related functions such as immigration facilitation service at Sea-ports, Integrated Check Posts and Airports and foreigner registration.
A valid UK, US, or Canada visa or residence permit can be used to enter Anguilla. Bermuda: Visa required [415] Visa required, except for a maximum stay of 3 months for holders of a multiple-entry visa issued by Canada, US or the UK, valid for at least 45 days beyond the period of intended stay in Bermuda. British Indian Ocean Territory
The certificate of pharmaceutical product (abbreviated: CPP) is a certificate issued in the format recommended by the World Health Organization (WHO), which establishes the status of the pharmaceutical product and of the applicant for this certificate in the exporting country; [1] it is often mentioned in conjunction with the electronic Common Technical Document (eCTD).
The Ministry of Food and Drug Administration is a ministry of the Government of Maharashtra. The ministry is responsible for consumer protection and regulating food and drug related issues in Maharashtra [1] [3] [4] The Ministry is headed by a cabinet level minister. Narhari Zirwal is current Minister of Food and Drugs Administration. [5]
The Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA) is a piece of American regulatory legislation signed into law on July 9, 2012.It gives the United States Food and Drug Administration (FDA) the authority to collect user fees from the medical industry to fund reviews of innovator drugs, medical devices, generic drugs and biosimilar biologics.
Title 21 is the portion of the Code of Federal Regulations that governs food and drugs within the United States for the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), and the Office of National Drug Control Policy (ONDCP). [1] It is divided into three chapters: Chapter I — Food and Drug Administration